Management of comorbid bipolar disorder and substance abuse

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Rates of alcohol and other substance abuse or dependence disorders are substantially higher in persons with bipolar disorders than in the general population, reaching approximately 61% in patients with bipolar I disorder. As a result, clinicians must be prepared to treat substance use disorders and bipolar disorder simultaneously. This presentation reviews data from the 4 published randomized, controlled trials of pharmacotherapy (lithium, carbamazepine, valproate, and quetiapine) in this population. Also reviewed are data from promising open-label, uncontrolled trials. While the results of published research have been generally positive and support the efficacy and tolerability of several agents from different classes in patients with a dual diagnosis of bipolar disorder and substance abuse or dependence, more randomized, controlled research is needed.

Original languageEnglish (US)
Pages (from-to)e05
JournalJournal of Clinical Psychiatry
Issue number8
StatePublished - Aug 2006

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'Management of comorbid bipolar disorder and substance abuse'. Together they form a unique fingerprint.

Cite this